Navigation Links
Redefining what it means to be a prion

CAMBRIDGE, Mass. (April 2, 2009) Whitehead Institute researchers have quintupled the number of identifiable prion proteins in yeast and have further clarified the role prions play in the inheritance of both beneficial and detrimental traits.

"The big debate in the field is are the prions functional are they evolved to be prions, or are they always a disease, as in "mad cow'" disease in mammals," says Randal Halfmann, a research assistant in Whitehead Member Susan Lindquist's lab, and coauthor of the paper featured on the cover of the April 3 issue of the journal Cell. "We wanted to find more prions and see what they're doing, so we could answer that question."

The Lindquist lab's work further alters the way researchers view prions, from biological anomalies to mediators of trait inheritance and adaptations to fluctuating environments. work shifts the way researchers view prions, from being a biological anomaly to a key

Prions' bad reputation was fixed in the public's mind by "mad cow" disease. In the late 1980s, an unidentified disease infected more than 100,000 British cows and spread to humans, eventually killing more than 200 people. The disease causes progressive degeneration of physical and mental abilities, which ultimately lead to death.

Scientists found the infectious agent was a prion, a misfolded version of the PrP protein found clumped together in brain cells. Brain matter in PrP-infected animals takes on a spongy appearance, lending the condition its formal name, bovine spongiform encephalitis (BSE).

Unlike other proteins, the misfolded PrP protein is transmissible. When the misfolded PrP protein is introduced to healthy cells, it can convert normally-folded PrP proteins to its misfolded shape and cause a clumping cascade characteristic of prions.

Over the years, researchers have identified a small number of other prions in humans and other animals, most of which cause degenerative neurological diseases, including scrapie in sheep and goats, and Creutzfeldt-Jakob disease in humans. A few prions have also been found in model organisms, such as yeast.

Believing the number of prions in yeast is higher than the four identified, researchers in Lindquist's lab devised a high-throughput method to scan the entire yeast genome, detect probable prion-coding sequences, and confirm that the resulting proteins are in fact prions. Lindquist says, "The approach required a lot of assay development and a great deal of work but the results were very exciting."

The scan located about 200 candidate prion-coding sequences in the yeast genome. The top 100 candidate proteins were tested for up to three hallmarks of prions: their tendency in cells to form clumps that remain intact when exposed to a detergent capable of unfolding most proteins; the ability of the proteins to clump in a Petri dish in the absence other cellular factors; and the ability of the proteins to replicate indefinitely in cells.

Applying their set of tests, the researchers found 24 prion candidates meeting all three criteria. Included in that number were all four of the known yeast prions.

"No one had taken such a broad approach to look for prions in any genome," says Simon Alberti, a Lindquist postdoctoral researcher and co-author of the paper. "And the results from work in yeast cells, and the in vitro work overlapped and supported each other very nicely."

Alberti and Halfmann hypothesize that prions in yeast prepare individual organisms for changes in the environment. Prions in cells are known to switch back and forth between a clumping, infectious stage and a non-infectious stage. When yeast is stressed, this switching occurs at a higher rate, which may give the yeast a better chance to adapt to challenging conditions.

For example, if a grape dusted with yeast falls from the vine and into a puddle, the waterlogged yeast's environment changes drastically. Various prions in the yeast cells may switch from inactive to active or active to inactive to help the cells survive under water. Some of those activation switches help the yeast, but some do not.

"We think that the fact that prions are sometimes beneficial and sometimes detrimental for the yeast is at the heart of their biology that they present a sort of bet-hedging strategy, where in some circumstances it's good to be in the prion state and in some cases it's not," says Whitehead Member and Howard Hughes Medical Institute Investigator Susan Lindquist.

This research opens several additional avenues of study, including the application of similar strategies to find additional yeast prions, thorough testing of prions in vivo and in vitro, and scanning of other organisms' genomes for prion candidates.


Contact: Nicole Giese
Whitehead Institute for Biomedical Research

Related biology news :

1. Less Arctic ice means higher risks, experts warn
2. Bad news for coastal ocean: less fish out, means more nitrogen in
3. Scientists demonstrate means of reducing Alzheimers-like plaques in fly brain
4. Researchers devise means to create blood by identifying earliest stem cells
5. Shorter wait means longer life for kidney transplant candidates
6. Self-digestion as a means of survival
7. Prions and retroviruses -- an unholy alliance?
8. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
9. Lymph nodes can be key in spreading prion infectivity
10. Scripps scientists develop new tests that identify lethal prion strains quickly and accurately
11. Prions show their good side
Post Your Comments:
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology: